Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
4.850
+0.030 (0.62%)
Dec 3, 2024, 12:33 PM EST - Market open
Aldeyra Therapeutics Market Cap
Aldeyra Therapeutics has a market cap or net worth of $288.82 million as of December 3, 2024. Its market cap has increased by 97.14% in one year.
Market Cap
288.82M
Enterprise Value
229.90M
1-Year Change
97.14%
Ranking
Category
Stock Price
$4.85
Market Cap Chart
Since May 2, 2014, Aldeyra Therapeutics's market cap has increased from $37.20M to $288.82M, an increase of 676.39%. That is a compound annual growth rate of 21.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 2, 2024 | 287.00M | 38.98% |
Dec 29, 2023 | 206.50M | -49.34% |
Dec 30, 2022 | 407.60M | 75.39% |
Dec 31, 2021 | 232.40M | -12.73% |
Dec 31, 2020 | 266.30M | 63.98% |
Dec 31, 2019 | 162.40M | -25.44% |
Dec 31, 2018 | 217.80M | 67.54% |
Dec 29, 2017 | 130.00M | 93.16% |
Dec 30, 2016 | 67.30M | 2.12% |
Dec 31, 2015 | 65.90M | 63.93% |
Dec 31, 2014 | 40.20M | 8.06% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vanda Pharmaceuticals | 300.29M |
Atai Life Sciences | 298.69M |
aTyr Pharma | 296.32M |
Perspective Therapeutics | 294.01M |
Rezolute | 292.03M |
uniQure | 291.00M |
Aclaris Therapeutics | 290.72M |
Lexicon Pharmaceuticals | 290.53M |